Month: September 2021

GXO Deploys Display Wearable Scanners that Boost Productivity

Written by Customer Service on September 14, 2021. Posted in Public Companies.

GREENWICH, Conn., Sept. 14, 2021 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, has deployed nearly 400 state-of-the-art display wearable scanners in warehouses in the UK, France and the Netherlands, Italy and Spain. The lightweight glove scanners speed up bar code reading, by up to 4 seconds per scan compared to traditional handheld units, while offering hands-free operations. GXO is using ProGlove’s MARK family of wearable scanners for picking, packing, shipping and inbound processing with MARK Display in pilot programs for major ecommerce and DIY customers. The wearable scanners increase precision in fast-paced logistics environments and provide critical information such as storage location, product identifier and quantity remaining directly to the user’s hand....

Matinas BioPharma Announces Webcast of Presentation at the H.C. Wainwright Global Investment Conference

Written by Customer Service on September 14, 2021. Posted in Public Companies.

BEDMINSTER, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, presented a Company overview at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021. A webcast of the Company’s presentation is available immediately on-demand via the IR Calendar page of the Investors section of the Company’s website (www.matinasbiopharma.com). A webcast replay will be accessible for 90 days following the event. About Matinas BioPharma Matinas BioPharma is a biopharmaceutical company focused on improving the intracellular delivery of critical therapeutics through its paradigm-changing lipid nanocrystal (LNC) delivery platform. The Company is developing its own internal portfolio of products as...

Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related Hyperinflammation

Written by Customer Service on September 14, 2021. Posted in Public Companies.

Based on a recently completed preclinical study performed at Michigan State University, Gb Sciences’ preclinical data supports further development of their novel cannabinoid-containing complex mixtures as anti-inflammatory therapies for hyperinflammatory conditions associated with COVID-19 and other life-threatening inflammatory conditions.Gb Sciences, Inc.Gb Sciences, Inc.LAS VEGAS, Sept. 14, 2021 (GLOBE NEWSWIRE) — Gb Sciences, Inc. (OTCQB: GBLX) received positive proof-of-concept data from a human immune cell model supporting their proprietary cannabinoid-containing complex mixtures (CCCM) designed for the suppression of COVID-related cytokine release syndromes (CRS) while preserving key anti-viral immune responses. Based on this new positive proof-of-concept data, Gb Sciences converted their provisional...

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model

Written by Customer Service on September 14, 2021. Posted in Public Companies.

Targeted testing run rate of 300 diabetic kidney disease patients per week in calendar Q4 2021 NEW YORK and SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD). KidneyIntelX enables a shift in focus from care coordination efforts focused on Mount Sinai’s late-stage kidney disease patients to a focus on patients with early stages of the disease where prognosis and treatment with population health care navigation assistance can improve patient care and outcomes and generate cost savings....

Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) in Patients with Head and Neck Cancer

Written by Customer Service on September 14, 2021. Posted in Public Companies.

Event to be webcast on Thursday, September 23 at 11:00 a.m. ET Phase 3 ROMAN trial of avasopasem manganese, Galera’s lead candidate for SOM in patients with head and neck cancer, expected to read out in 4Q 2021 MALVERN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that the Company will host a virtual Key Opinion Leader event on radiotherapy-induced severe oral mucositis (SOM) in patients with head and neck cancer on Thursday, September 23 at 11:00 a.m. ET. Dr. Carryn Anderson, Clinical Associate Professor of Radiation Oncology at the University of Iowa, will provide a review of the current...

ELSE Announces Venue Change to the Special Investors and Shareholders Conference planned in New York City

Written by Customer Service on September 14, 2021. Posted in Public Companies.

The Company will host the upcoming conference as a virtual event due to COVID-19 travel and assembly restrictions. Else expects to provide a special business update at the Company conference VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, provides an update on its upcoming investors conference. Due to the COVID-19 travel and assembly restrictions in the U.S., the company will postpone the physical event scheduled originally for October 4th and will host a virtual online event for investors and shareholders during the month of November 2021. Final date, time, registration and RSVP links will be provided separately. “We are deeply disappointed the global...

Ketamine One Engages Psychology & Counselling Services Group for IRP Health

Written by Customer Service on September 14, 2021. Posted in Public Companies.

PCSG to Provide Psychology, Therapy, Dietary and Other Mental Health Services for the Wholly-Owned Ketamine One Subsidiary VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has entered into an agreement with Psychology & Counselling Services Group (“PCSG”) to provide psychology, therapy, dietary and other mental health services for Ketamine One’s subsidiary, IRP Health Ltd. (“IRP”), as early as October of 2021. Practicing since 2006, the PCSG team of over 35 mental health professionals have treated over 11,000 patients through their established programs including...

Green Thumb Industries to Open Rise Bloomfield in New Jersey, Its 65th Retail Location in the Nation, on September 15

Written by Customer Service on September 14, 2021. Posted in Public Companies.

CHICAGO and BLOOMFIELD, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (GTI) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced it will open Rise Bloomfield, the Company’s third store in New Jersey and 65th in the nation. Profits from the first day of sales will be donated to the Bloomfield Youth Aid Foundation, a non-profit organization dedicated to providing services to Bloomfield youth, including scholarship funds, toy drives and summer youth programs. “We are excited to open Rise Bloomfield, our third store in New Jersey, as we continue to see sweeping acceptance for cannabis throughout the nation and specifically the East Coast,” said Green Thumb Founder and Chief Executive Officer Ben Kovler. “Community is at the core...

Osisko Confirms New High-Grade Gold Discovery

Written by Customer Service on September 14, 2021. Posted in Public Companies.

Golden Bear Expands to 3 Mineralized Zones 67.10 g/t Au Over 2.0 Metres, 62.15 g/t Au Over 2.0 Metres, 38.67 g/t Au Over 2.2 Metres 50,000 Metre Drill Program Begins TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Osisko Mining Inc. (OSK:TSX. “Osisko” or the “Corporation”) is pleased to provide new results from the expanding Golden Bear discovery located approximately 1000 metres north of its 100% owned high-grade Windfall gold deposit, located in the Abitibi greenstone belt, Urban township, Eeyou Istchee James Bay, Québec. Additional reconnaissance drilling has confirmed the Golden Bear discovery zone (“D1”) and has also identified two new mineralized zones (“D2” and “D3”). Drilling 50 metres south-east from D1 has defined the presence of parallel gold zone D2. Drilling 200 metres south-east of D1 has defined...

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

Written by Customer Service on September 14, 2021. Posted in Mergers And Acquisitions.

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience, Inc. (“Agena”) for a cash purchase price of $300 million, subject to customary purchase price adjustments. Mesa expects to finance the all-cash transaction with a combination of cash on hand and proceeds from our credit facility. The transaction is expected to be completed in Mesa’s third fiscal quarter ending December 31, 2021, and is subject to customary conditions, including receipt of applicable regulatory approvals. Agena is headquartered in San Diego,...

Month: September 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals